Roche Pegasys/Copegus Dosing Should Be Set By Genotype, FDA Cmte. Says

Treatment with Roche's Pegasys/Copegus should be dosed according to hepatitis C virus genotype in order to optimize the product's risk/benefit ratio, FDA's Antiviral Drugs Advisory Committee recommended